---
accession : E-GEOD-7538
platform  : A-AFFY-44
pathway   : NFkB
cells     : human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients
treatment : 7.5 micromolar parthenolide (PTL)
effect    : inhibiting
hours     : 6

control   :
    - GSE7538GSM182630
    - GSE7538GSM182632
    - GSE7538GSM182634
    - GSE7538GSM182636
    - GSE7538GSM182638
    - GSE7538GSM182640
    - GSE7538GSM182642
    - GSE7538GSM182644
    - GSE7538GSM182648
    - GSE7538GSM182650
    - GSE7538GSM182652
perturbed :
    - GSE7538GSM182629
    - GSE7538GSM182631
    - GSE7538GSM182633
    - GSE7538GSM182635
    - GSE7538GSM182637
    - GSE7538GSM182639
    - GSE7538GSM182641
    - GSE7538GSM182643
    - GSE7538GSM182647
    - GSE7538GSM182649
    - GSE7538GSM182651
...
